Tag: Piramal Enterprises Limited

Piramal Capital & Housing Finance LimitedSecured NCD PublicTranche I – Issue Opens on July 12,Coupon Rate Upto 9.00% p.a.

Chennai: Wholly owned subsidiary of Piramal Enterprises Ltd,Piramal Capital & Housing Finance Limited (PCHFL), a non-deposit taking housing finance company, into wholesale and retail funding, has announced the issue of secured, rated, listed, redeemable, non-convertible debentures of the face value of Rs. 1,000 each(“Secured NCDs”). The Tranche 1 Issue opens on July 12, 2021 and closes on July 23, 2021(with an option of early closure or extension).

The Tranche IIssue hasa base issue size of Rs. 200 croreswith an option to retain oversubscription up toRs 800 crores, aggregating up to Rs. 1,000 crores (“Tranche 1 Issue”). The NCDs are proposed to be listed on BSE and NSE (collectively, “Stock Exchanges”) with BSE as the Designated Stock Exchange for the Issue. The NCDs have been rated CARE AA(CWD) (Under Credit Watch with Developing Implications)by CARE Ratings Ltd and ICRA (AA) with outlook (negative) by ICRA Ltd.

The terms of each series of NCDs, offered under Tranche I Issue are set out below:

Series I II III* IV V
Interest Type Fixed Fixed Fixed Fixed Fixed
Frequency of Interest Payment Annual Cumulative Annual Annual Annual
Type of NCDs Secured
Minimum Application ₹10,000 (10 NCDs) across all Series
In Multiples of thereafter (₹) ₹ 1,000/- (1 NCD)
Face Value/ Issue Price of NCDs (₹/NCD) ₹ 1,000
Tenor from Deemed Date of Allotment 26 months 26 months 36 months 60 months 120 months
Coupon (% per annum) for NCD Holders in Category I & II 8.10% NA 8.25% 8.50% 8.75%
Coupon (% per annum) for NCD Holders in Category III & IV 8.35% NA 8.50% 8.75% 9.00%
Effective Yield (% per annum) for NCD Holders in Category

I & II

8.12% 8.10% 8.24% 8.50% 8.74%
Effective Yield (% per annum) for NCD Holders in Category

III & IV

8.37% 8.35% 8.49% 8.75% 8.99%
Mode of InterestPayment Through various mode available
Amount (₹ / NCD) on Maturity for NCD Holders in Category

I & II

₹1,000 ₹1184.20 ₹1,000 ₹1,000 ₹1,000
Amount (₹ / NCD) on Maturity for NCD Holders in Category

III & IV

₹1,000 ₹1190.15 ₹1,000 ₹1,000 ₹1,000
Put and Call Option Not Applicable

 

  • *Our Company would allot the Series III NCDs, as specified in this Tranche I Prospectus to all valid Applications, wherein the Applicants have not indicated their choice of the relevant Series of NCDs.
  • With respect to Options where interest is to be paid on an annual basis, relevant interest will be paid on each anniversary of the Deemed Date of Allotment on the face value of the NCDs. The last interest payment under annual Options will be made at the time of redemption of the NCDs.
  •  Subject to applicable tax deducted at source, if any

PCHFL is a wholly owned subsidiary of Piramal Enterprises Limited (“PEL”), which is the flagship company of thePiramal Group, registered as a non-deposit taking housing finance company with the National Housing Bank (NHB). Our journey in financial services started in 2010, with the setup of Piramal Finance Ltd (PFL) and over the years, we have built a lendingplatform to serve the needs of corporate and individual customers.In terms of retail housing finance, we have been offering housing loans to retail customers – in addition to other retaillending products.We have also entered into business partnerships withfintech’s and other consumer focused entities of strategic significance to optimize our vision of multi-product digital lending. We have pivotedour business strategy from focusing on large ticket affluent home loans to the prime segment of affordable housing loans andmass affluent housing loans. Our retail housing portfolio has grown from ₹ 1,32,618 lakh in Fiscal 2018 (constituting 4% ofour loan book) to ₹ 4,43,127 lakh as of Fiscal 2021 (constituting 13.7% of our loan book) in a short span of three years.

The company as on March 31, 2020 had a CRAR of 34.89%, higher than other tier 1 and tier 2 players in the housing finance segment(Source: CRISIL Report) and currently stands at 32.30% for FY21.

The Lead Managers to the issue areA. K. Capital Services Limited,Edelweiss Financial Services Limited,JM Financial Limited andTrust Investment Advisors Private Limited.

Capitalised terms not defined herein shall have the same meaning as assigned to such terms in the Shelf Prospectus and Tranche I Prospectus each dated June 30, 2021.

Allotments, in consultation with the Designated Stock Exchange, shall be made on date priority basis i.e. first-come first serve basis, based on the date of upload of each Application in to the electronic book with Stock Exchange, in each Portion subject to the Allocation Ratio indicated in the Tranche Prospectus

#For further details please refer Shelf Prospectus and Tranche I Prospectus each dated June 30, 2021

DISCLAIMER: Piramal Capital & Housing Finance Limited (“Piramal”) is proposing, subject to receipt of requisite approvals, market conditions and other considerations, a public offer of secured, redeemable, non-convertible debentures in the nature of debentures (“NCDs”). This announcement does not constitute an offer to sell or solicitation of an offer or invitation to buy any securities in any jurisdiction. Investment in the NCDs involves a degree of risk. Investors should see the tranche I prospectus dated June 30, 2021 read with the shelf prospectus dated June 30, 2021 (“Shelf Prospectus”) of Piramal Capital & Housing Finance Limited filed with the Registrar of Companies, Maharashtra at Mumbai and submitted to BSE Limited (“BSE”), National Stock Exchange of India Ltd.(“NSE”)] and Securities and Exchange Board of India (“SEBI”), including the section titled “Risk Factors” beginning on page 17 of the Shelf Prospectus, available on the websites of the Issuer at www.pchf.in, BSE at www.bseindia.com, NSE at www.nseindia.com, SEBI at www.sebi.gov.in and the websites of the lead managers at www.akgroup.co.in, www.edelweissfin.com, www.jmfl.com and www.trustgroup.in.

ALLOTMENT ON FIRST CUM FIRST SERVE BASIS:NCD allotment will be made in dematerialised form only. Allotments in consultation with the lead managers and designated stock exchange shall be made on first come first serve basis based on the date of upload of each application into the electronic platform of the stock exchange, in each portion subject to the allocation ratio. for further details please refer to the Shelf Prospectus dated June 30, 2021 and Tranche I Prospectus dated June 30, 2021. Allotment in the public issue of debt securities should be made on the basis of date of upload of each application into the electronic book of stock exchange. However on the date of over subscription, the allotment should be made to the applicants on proportionate basis.

DISCLAIMER CLAUSE OF NSE: As required, a copy of this offer document has been submitted to National Stock Exchange of India Limited (hereinafter referred to as NSE). NSE has, vide its letters ref.: NSE/LIST/D/2021/0039 dated April 09, 2021 and NSE/LIST/C/2021/0435 dated June 28, 2021 extending the validity of the in-principal approval, given permission to the Issuer to use the exchange’s name in this offer document as one of the stock exchanges on which this Issuer’s securities are proposed to be listed. The exchange has scrutinized this offer document for its limited internal purpose of deciding on the matter of granting the aforesaid permission to this Issuer. It is to be distinctly understood that the aforesaid permission given by NSE should not in any way be deemed or construed that the offer document has been cleared or approved by NSE; nor does it in any manner warrant, certify or endorse the correctness or completeness of any of the contents of this offer document; nor does it warrant that this Issuer’s securities will be listed or will continue to be listed on the exchange; nor does it take any responsibility for the financial or other soundness of this Issuer, its promoter, its management or any scheme or project of this issuer. every person who desires to apply for or otherwise acquire any securities of this Issuer may do so pursuant to independent inquiry, investigation and analysis and shall not have any claim against the exchange whatsoever by reason of any loss which may be suffered by such person consequent to or in connection with such subscription /acquisition whether by reason of anything stated or omitted to be stated herein or any other reason whatsoever.

DISCLAIMER CLAUSE OF BSE: BSE Limited (“the Exchange”) has given, vide it’s approval letter dated April 09, 2021, permission to this Company to use the Exchange’s name in this offer document as one of the stock exchanges on which this Company’s securities are proposed to be listed. The exchange has scrutinized this Offer Document for its limited internal purpose of deciding on the matter of granting the aforesaid permission to this Company. The exchange does not in any manner: a. warrant, certify or endorse the correctness or completeness of any of the contents of this offer document; or b. warrant that this company’s securities will be listed or will continue to be listed on the exchange; or c. take any responsibility for the financial or other soundness of this company, its promoter, its management or any scheme or project of this company and it should not for any reason be deemed or construed that this offer document has been cleared or approved by the Exchange. Every person who desires to apply for, or otherwise acquires any securities of this Company may do so pursuant to independent inquiry, investigation and analysis and shall not have any claim against the Exchange whatsoever by reason of any loss which may be suffered by such person consequent to or in connection with such subscription/acquisition whether by reason of anything stated or omitted to be stated herein or for any other reason whatsoever.

DISCLAIMER OF NSE TO USE ONLINE BIDDING PLATFORM : It is also to be distinctly understood that the approval given by the Exchange is only to use the software for participating in system of making application process. It is to be distinctly understood that the permission given by National Stock Exchange of India Ltd. (NSEIL) to use their network and Online Platform for facilitating applications for public issue of debt securities shall not in any way be deemed or construed as compliance with statutory and other requirements by (name of the company), BRLM, etc. is cleared or approved by NSEIL; nor does it in any manner warrant, certify or endorse the correctness or completeness of any of the compliance with the statutory and other requirements nor does it take any responsibility for the financial or other soundness of this Issuer, its promoters, its management or any scheme or project of this Issuer.

It is also to be distinctly understood that the approval given by NSEIL should not in any way be deemed or construed that the prospectus has been cleared or approved by NSE; nor does it in any manner warrant, certify or endorse the correctness or completeness of any of the contents of this prospectus; nor does it warrant that the securities will be listed or will continue to be listed on NSE.

DISCLAIMER OF BSE TO USE ONLINE BIDDING PLATFORM: It is to be distinctly understood that the permission given by the Exchange to use their network and software of the Online system should not in any way be deemed or construed that the compliance with various statutory requirements approved by the Exchange; nor does it in any manner warrant, certify or endorse the correctness or completeness of any of the compliance with the statutory and other requirements nor does it take any responsibility for the financial or other soundness of this Company, its promoters, its management or any scheme or project of this Company.

It is also to be distinctly understood that the approval given by the Exchange is only to use the software for participating in system of making application process.

DISCLAIMER CLAUSE OF RATING AGENCIES

CARE RATINGS LIMITED: CARE’s ratings are opinions on the likelihood of timely payment of the obligations under the rated instrument and are not recommendations to sanction, renew, disburse or recall the concerned bank facilities or to buy, sell or hold any security. CARE’s ratings do not convey suitability or price for the investor. CARE’s ratings do not constitute an audit on the rated entity. CARE has based its ratings/outlooks on information obtained from sources believed by it to be accurate and reliable. CARE does not, however, guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errorsor omissions or for the results obtained from the use of such information. Most entities whose bank facilities/instruments are rated by CARE have paid a credit rating fee, based on the amount and type of bank facilities/instruments. CARE or its subsidiaries/associates may also have other commercial transactions with the entity. In case of partnership/proprietary concerns, the rating /outlook assigned by CARE is, inter-alia, based on the capital deployed by the partners/proprietor and the financial strength of the firm at present. The rating/outlook may undergo change in case of withdrawal of capital or the unsecured loans brought in by the partners/proprietor in addition to the financial performance and other relevant factors. CARE is not responsible for any errors and states that it has no financial liability whatsoever to the users of CARE’s rating. Our ratings do not factor in any rating related trigger clauses as per the terms of the facility/instrument, which may involve acceleration of payments in case of rating downgrades. However, if any such clauses are introduced and if triggered, the ratings may see volatility and sharp downgrades.

ICRA LIMITED:ICRA ratings should not be treated as recommendation to buy, sell or hold the rated debt instruments. ICRA ratings are subject to a process of surveillance, which may lead to revision in ratings. An ICRA rating is a symbolic indicator of ICRA’s current opinion on the relative capability of the issuer concerned to timely service debts and obligations, with reference to the instrument rated. Please visit our website www.icra.in or contact any ICRA office for the latest information on ICRA ratings outstanding. All information contained herein has been obtained by ICRA from sources believed by it to be accurate and reliable, including the rated issuer. ICRA however has not conducted any audit of the rated issuer or of the information provided by it. While reasonable care has been taken to ensure that the information herein is true, such information is provided ‘as is’ without any warranty of any kind, and ICRA in particular, makes no representation or warranty, express or implied, as to the accuracy, timeliness or completeness of any such information. Also, ICRA or any of its group companies may have provided services other than rating to the issuer rated. All information contained herein must be construed solely as statements of opinion, and ICRA shall not be liable for any losses incurred by users from any use of this publication or its contents.

TIMING: For further details refer to section titled “Issue Related Information” on page 33 of the Tranche I Prospectus dated June 30, 2021. Allotment in the public issue of debt securities should be made on the basis of date of upload of each application into the electronic book of the stock exchange. However, on the date of oversubscription, the allotments should be made to the applicants on proportionate basis.

The Tranche I Issue shall remain open for subscription on Working Days from 10:00 a.m. to 5:00 p.m. (Indian Standard Time), during the period indicated above, with an option for early closure or extension by such period as may be decided by the Board of Directors or a duly constituted committee thereof. In the event of such early closure or extension of the Tranche I Issue, our Company shall ensure that public notice of such early closure or extension is published on or before day of such early date of closure or initial Tranche I issue closing date, through an advertisement in all the newspapers in which pre-issue advertisement and advertisement for opening or closure of the Tranche I Issue has been given. On the TrancheI Issue Closing Date, Application Forms will be accepted only between 10:00 a.m. to 3:00 p.m. and uploaded until 5:00 p.m. (Indian Standard Time) or such extended time as may be permitted by the Stock Exchanges. Further, pending mandate requests for bids placed on the last day of bidding will be validated by 5:00p.m. on one Working Day post the Tranche I Issue Closing Date. refer to section titled “Issue Related Information” on page 33 of the Tranche I Prospectus.

Piramal Enterprises Ltd. to Cover Cost for COVID-19 Vaccination for All its Employees and Family Members

Mumbai: Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302, 912460) today announced that it will absorb the cost of COVID-19 vaccination for all its employees and their immediate family members that are eligible and choose to receive the vaccination in India. The company has also set up virtual vaccine helpdesks across its offices in India to address employee queries on the vaccination including enabling registrations, information on vaccination centres, etc. Opting for the vaccine is at the discretion of employees and they are urged to make an informed decision for themselves and their family.

“Driven by our values, we believe that employees are our greatest assets, and we remain committed to ensuring their wellbeing and welfare. We are happy to absorb the cost of the COVID-19 vaccination, as well as to support them through the process, should they choose to get vaccinated.” said Nandini Piramal, Executive Director, Piramal Enterprises Limited.

Piramal Group’s core values of Knowledge, Action, Care and Impact have been an integral part of the Company’s guiding philosophy of ‘Doing Well and Doing Good’. In line with this philosophy, the Company has undertaken this initiative to help about ~27000 employees and their families get vaccinated free of cost, encouraging more people towards a safer future.

Piramal Group Announces the Appointment of Kalpesh Kikani as CEO, Piramal Alternatives

Mumbai, India: Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302) today announced the appointment of Kalpesh Kikani as Chief Executive Officer (CEO) of its INR 11,000+ crore AUM Alternatives Business managed through its subsidiaries and joint ventures, which leverages Piramal Group’s long standing partnerships with marquee Global investors such as CDPQ, CPPIB, APG, Ivanhoé Cambridge and Bain Capital.

Kalpesh comes with over twenty five years of expertise in investing and financial services including a decade as founding Managing Director at AION Capital (a JV between Apollo Global Management and ICICI Group). AION Capital is a pioneer in building an India focused private equity business with a focus on value, credit and control. At AION, Kalpesh led both fund raising and deployment of over $1.25 billion of capital and served on the boards of several its portfolio companies.

Previously, Kalpesh spent over 15 years at ICICI Bank. Kalpesh played a significant role in building the bank’s commercial banking business to over $10 billion in assets and the structured finance business to over $ 5 billion in assets. Prior to that, Kalpesh setup and built the bank’s corporate and investment banking business in London to $ 4 billion in assets. Earlier, Kalpesh was part of the retail banking team at the time of the merger of ICICI Limited and ICICI Bank Limited. Kalpesh started his career at ICICI Limited in project finance where he participated in multibillion dollar corporate and infrastructure financing.

Kalpesh holds a Bachelor of Engineering Degree in Computer Science and an MBA in Finance from Bombay University and is a member of the CFA Institute, USA.

Commenting on the appointment, Anand Piramal, Executive Director, Piramal Group said, “We are delighted to welcome Kalpesh to the Piramal family. Kalpesh brings with him, rich experience in building an alternatives business of global scale and standard in India, a 25 year+ track record of successfully investing in India and strong relationships with leading global investors.

While globally, alternative assets have grown rapidly over the last 10 years to over US$ 11 trillion, in India the asset class has grown much faster at over a 20% CAGR, making it one of India’s highest growth opportunities.

Our desire is to create a world class Alternatives business across multiple asset classes that helps fill a significant deficit of long-term risk capital needed by Indian businesses as they help fuel India’s journey to a $5 trillion economy. The Alternatives business, is another step in building a new age, digitally driven, diversified financial services conglomerate at Piramal.”

“I am excited to join the Piramal team,” said Kalpesh Kikani, CEO, Piramal Alternatives. “Piramal Alternatives has a great business model, has partnered with best-in-class global investors, and is uniquely positioned to build a leading home grown Alternatives business across private debt, private equity, and infrastructure, amongst others. As the Indian economy evolves, Piramal Alternatives can be a significant provider of customized financing solutions to high quality Indian corporates who are looking to maximize their potential.”

Piramal Enterprises Appoints Anjali Bansal as Independent Director on its Board

Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302, 912460) today announced the appointment of Anjali Bansal, Founder and Chairperson, Avaana Group as Independent Director to its Board with effect from November 19, 2020. Along with the recent two appointments of Independent Directors – Kunal Bahl, CEO & Co-Founder, Snapdeal, and Suhail Nathani, Managing Partner, Economic Law Practice, Anjali Bansal’s appointment to the PEL Board is aligned to the Company’s succession planning of the Independent Directors on its Board.

The appointment of these Independent Directors are reflective of diversity, deep sectoral expertise and rich experience to ensure continued robust discourse in PEL’s Boardroom. PEL has a unique business model run by a seasoned leadership team and under the purview of a quality Board that has always stood for highest standards of ethics and governance. Aligned with the evolving business model of the Company, as well as newer areas within the businesses that the Company is venturing into, PEL remains committed to its continued focus on corporate values, governance, quality and compliance, and to create long-term value for all its stakeholders.

Anjali Bansal is the Founder and Chairperson of Avaana Group which invests in and provides scaling up support to technology and innovation companies to deliver impact at scale. A former Non-Executive Chairperson of Dena Bank, Anjali was earlier a Global Partner and Managing Director with TPG Growth Capital. Prior to TPG, she was Global Partner and India CEO with Spencer Stuart and co-led their Asia Boards practice. She started her career as a strategy consultant with McKinsey and Co. in New York. Anjali has a rich knowledge of new economy companies and has been supporting them to leverage opportunities ahead of them while overcoming the challenges in their path to success. She will bring this understanding to the PEL Board as it continues on its journey and a new phase of its growth.

Anjali serves as an Independent Non-Executive Director on several leading boards including Siemens Ltd, Tata Power, Voltas and Delhivery. She has invested in and mentored various successful start-ups including Delhivery, UrbanClap, Darwinbox, Nykaa, and Lenskart. She is a member of the Young Presidents’ Organization, Charter Member of TiE, and is associated with NITI Aayog’s Women Entrepreneurship Platform, Digital Solutions, and Atal Innovation Mission.

Piramal Enterprises Limited Announces Consolidated Results for Q2 & H1 FY2021

Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302, 912460) today announced its consolidated results for the Second Quarter (Q2) and Half Year (H1) ended September 30, 2020.

 

Consolidated Financial Highlights
§  Balance Sheet:

–          Shareholders’ Equity increased by 28% to INR 34,739 Cr.* since Mar 19

–          39% reduction in Net Debt by nearly INR 22,000 Cr.* since Mar 2019

–          Net Debt-to-Equity of below 1x times* at entity-level

*Post Pharma deal closed in October 2020

 

§  Inflows / Borrowings:

–          Total inflows of ~INR 42,800 Cr. since April 2019, through equity and borrowing transactions

·         Raised long-term borrowings of ~INR 11,500 Cr. during H1 FY2021

–          Reduction in CPs to INR 2,100 Cr. as of Sep 2020 from INR 18,017 Cr. as of Sep 2018

 

§  P&L:

–          Revenue for Q2 FY21 increased by 1% YoY to INR 3,302 Cr.

–          Net Profit for Q2 FY21 increased by 14% YoY to INR 628 Cr.

–          Net Profit for H1 FY21 grew by 12% YoY to INR 1,124 Cr.

Mr. Ajay Piramal, Chairman, Piramal Enterprises Ltd. said, “We have delivered a resilient performance with net profit of INR 1,124 Crore for H1 FY21, despite adverse global environment. Continuing to focus on strengthening our balance sheet, over the past year, we brought in INR 18,000 Cr of capital and reduced our net debt-to-equity ratio to below 1x.

In Financial Services, we saw early signs of recovery across the key sectors that we lend to. Progressing on the stated strategy of diversifying the loan book, we will be launching our multi-product retail lending platform in November 2020.

The Pharma Business recorded a healthy improvement in both revenue growth and profitability. It also completed the 20% growth investment by The Carlyle Group – which is an affirmation of the robustness of the business model and consistency in performance. Both businesses are now at an inflection point, where we see a good runway for strong performances in the mid to long-term.”

 

 

Key Business Highlights
Financial Services Pharma
§  In line with our Strategy to diversify our book, launching the multi-product Retail Lending business in Nov-2020

 

§  Early trends indicate better performance of developer clients than assumed under stressed scenario for creating provisions

 

§  Continue to increase granularity of our wholesale loan book.

–          Exposure to only one account at >15% of the net worth of Financial Services

 

§  Conservative provisions of INR 3,037 Cr. as of Sep 2020, equivalent to 237% of GNPAs and 5.9% of overall loan book

 

§  Capital Adequacy Ratio at 34% (vs. 22% as of March 2019)

§  Closed fund raising deal with The Carlyle Group

–          Deal values our Pharma business at an Enterprise Value of USD 2.7 – 3.1 Bn.

–          Received INR 3523.40 Cr. as proceed from Pharma Fund raise.

§  Revenue of INR 1,441 Cr. (+9% YoY) with EBITDA margins of 23% for Q2FY2021

–          CDMO Revenue up 20% YoY

–          India Consumer Products up 25% YoY

 

§  Other Highlights

–          CDMO order book witnessing healthy growth

–          India Consumer Products business launched 15 products and 38 SKUs during the year

–          Complex Hospital Generics now seeing recovery

–          Cleared 4 regulatory inspections

Business-wise Revenue Performance                                                                             (INR Crores or as stated)
Net Sales break-up Quarter II ended Half year ended
30/9/20 30/9/19 % Change % Sales 30/9/20 30/9/19 % Change % Sales
Financial Services 1,861 1,954 -5% 56% 3,760 3,968 -5% 60%
Pharma 1,441 1,317 9% 44% 2,479 2,489 40%
Pharma CDMO 866 724 20% 26% 1,480 1,373 8% 24%
Complex Hospital Generics 438 477 -8% 13% 763 891 -14% 12%
India Consumer Products 140 112 25% 4% 244 222 10% 4%
Total 3,302 3,271 1% 6,239 6,457 -3%

 

Consolidated Financial Performance                                                                              (INR Crores or as stated)
Particulars Quarter II ended Half year Ended
30-Sep-20 30-Sep-19 % Change 30-Sep-20 30-Sep-19 % Change
Net Sales 3,302 3,271 1% 6,239 6,457 -3%
Non-operating other income 38 46 -18% 103 110 -7%
Total income 3,339 3,316 1% 6,342 6,568 -3%
Other Operating Expenses 1,278 1,188 8% 2,369 2,363 0%
Expected Credit loss 24 -107 75 -152
OPBIDTA 2,038 2,236 -9% 3,898 4,357 -11%
Interest Expenses 1,156 1,337 -14% 2,260 2,665 -15%
Depreciation 139 128 9% 274 250 10%
Profit / (Loss) before tax & exceptional items 742 770 -4% 1,364 1,441 -5%
Exceptional items (Expenses)/Income 39 0 39 0
Income tax
Current Tax and Deferred Tax 204 258 -21% 365 474 -23%
DTA and MAT Credit written off 0 0 0 0
Profit/(Loss) after tax (before MI & Prior Period items) 578 512 13% 1,039 968 7%
Minority interest 0 0 0 0
Share of Associates 50 96 -48% 85 169 -50%
Net Profit/(Loss) after Tax from continuing operations 628 608 3% 1,124 1,137 -1%
Profit / (Loss) from Discontinued operations 0 -57 0 -137
Net Profit after Tax 628 551 14% 1,124 1,000 12%

 

Note: Figures in previous periods might have been regrouped or restated, wherever necessary to make them comparable to current period.

To download the results presentation and for further information on our financials, please visit our website: www.piramal.com

 

Kunal Bahl and Suhail Nathani Appointed Independent Directors of Piramal Enterprises

Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302, 912460) today announced the appointment of Kunal Bahl, CEO, Snapdeal and Suhail Nathani, Managing Partner, Economic Law Practice, as Independent Directors to its Board with effect from October 14, 2020.

Kunal Bahl, is the CEO & Co-Founder of Snapdeal.com, India’s leading, value-focused e-commerce marketplace that has raised capital from leading global investors such as Temasek, BlackRock, Mr. Ratan Tata, Softbank, Premji Invest, among others. Kunal has been the recipient of various awards including Ernst & Young Entrepreneur of the Year (start-up) (2014); Fortune Global 40 under 40 (2014); The Economic Times Entrepreneur of the Year (2015); The Joseph Wharton Award for Young Leadership (2018); The Economic Times Comeback Award (2019).

Kunal is also an active angel investor having invested in 120+ technology companies in India, US and South East Asia, across consumer internet, fintech, direct to consumer brands, AI and deep-tech. Some of his notable investments include Ola Cabs, Urban Company, Razorpay, Shadowfax, Mamaearth, among others.

Kunal has also been serving on the Board of Governors of ICRIER, a leading economic think-tank based in New Delhi, since 2015. He is a member of the Nasscom Executive Committee since 2019 and the current Chairman of the CII National E-commerce Committee. Kunal is an engineer from UPenn, with a business degree from The Wharton School, where he was a part of the prestigious Management & Technology Program.

Suhail Nathani, Managing Partner, Economic Law Practice (ELP), well-reputed for his expertise across M&A, regulatory, trade and competition laws. He has successfully represented India in WTO disputes before the Panel and Appellate Body in Geneva and was also part of the Competition Commission of India’s Working Group on Competition Policy, Advocacy and Advisory Functions.

Suhail has widely been recognised as a leading lawyer in his areas of practice and ranked in the top 30 International Trade practitioners in the world by the Best of the Best Expert Guides. He is also named in the India Business Law Journal’s A-List as India’s Top 100 Lawyers.

Suhail is an Honorary Adjunct Professor at Jindal Global Law School in India; serves on the Apex Advisory Board at Adani Institute of Infrastructure Law and on Boards of Somaiya Vidyavihar and Salaam Bombay Foundation. He also serves as a Trustee for a leading Mutual Fund in India. Apart from India, he is also admitted to the State Bar of New York. Suhail earned his Master’s Degree at Cambridge University, England and an LL.M. from Duke University, USA.